Your browser doesn't support javascript.
loading
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
Guerini-Rocco, Elena; Gray, Kathryn P; Fumagalli, Caterina; Reforgiato, Marta Rita; Leone, Isabella; Rafaniello Raviele, Paola; Munzone, Elisabetta; Kammler, Roswitha; Neven, Patrick; Hitre, Erika; Jerusalem, Guy; Simoncini, Edda; Gombos, Andrea; Deleu, Ines; Karlsson, Per; Aebi, Stefan; Chirgwin, Jacquie; Di Lauro, Vincenzo; Thompson, Alastair; Graas, Marie-Pascale; Barber, Matthew; Fontaine, Christel; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Müller, Bettina; O'Reilly, Seamus; Di Leo, Angelo; Goldhirsch, Aron; Viale, Giuseppe; Barberis, Massimo; Regan, Meredith M; Colleoni, Marco.
Affiliation
  • Guerini-Rocco E; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan and University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy. Elena.GueriniRocco@ieo.it.
  • Gray KP; International Breast Cancer Study Group Statistical Center, Frontier Science Foundation, and Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Fumagalli C; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Reforgiato MR; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Leone I; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Rafaniello Raviele P; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Munzone E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Kammler R; International Breast Cancer Study Group, Bern, Switzerland.
  • Neven P; Multidisciplinary Breast Center, University Hospitals, KU Leuven, Leuven, Belgium.
  • Hitre E; National Institute of Oncology, Budapest, Hungary.
  • Jerusalem G; CHU Liège and Liège University, Liège, Belgium.
  • Simoncini E; ASST Spedali Civili di Brescia, Brescia, Italy.
  • Gombos A; Institute Jules Bordet, Brussels, Belgium.
  • Deleu I; AZ Nikolaas, Sint-Niklaas, Belgium.
  • Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy/Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
  • Aebi S; Lucerne Cantonal Hospital and University of Bern, Bern, Switzerland.
  • Chirgwin J; Box Hill and Maroondah Hospitals, Monash University, Melbourne, Victoria, Australia.
  • Di Lauro V; CRO-Aviano, Aviano, Italy.
  • Thompson A; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Graas MP; CHC Clinique St. Joseph, Liège, Belgium.
  • Barber M; Western General Hospital, Edinburgh, Scotland.
  • Fontaine C; UZ Brussel, Brussels, Belgium.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
  • Gavilá J; Fundación Instituto Valenciano de Oncologia, Valencia, Spain.
  • Kuroi K; Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo City, Tokyo, Japan.
  • Müller B; Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile.
  • O'Reilly S; Cancer Trials Ireland, Glasnevin, Dublin, Ireland.
  • Di Leo A; Hospital of Prato-AUSL Toscana Centro, Prato, Italy.
  • Goldhirsch A; International Breast Cancer Study Group, Bern, Switzerland and MultiMedica, Milan, Italy.
  • Viale G; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, International Breast Cancer Study Group Central Pathology Office and University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy.
  • Barberis M; Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Regan MM; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology, and the International Breast Cancer Study Group, Milan, Italy.
Clin Cancer Res ; 27(2): 504-512, 2021 01 15.
Article in En | MEDLINE | ID: mdl-33082214
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen / Postmenopause / Letrozole Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen / Postmenopause / Letrozole Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: